Influence of nurses on compliance with breast screening recommendations in an organized breast screening program

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 3, 2010, Pages 697-706

  Chiarelli, Anna M ^a   Majpruz, Vicky ^a   Brown, Patrick ^a   Theriault, Marc ^a   Edwards, Sarah ^a   Shumak, Rene ^a   Mai, Verna ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER SCREENING; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; NURSE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; CANCER CARE FACILITIES; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NURSES; PATIENT COMPLIANCE;

EID: 77949689665     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0884     Document Type: Article

References (41)

1. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
2. IARC Working Group. Efficacy of screening. In: Vainio H, Bianchini F, editors. Handbooks of cancer prevention: breast cancer screening. Lyon (France): IARC Press; 2002, p. 87-117.
3. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteenyear effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
4. Tabar L, Fagerberg CJ, Gad A, et al, Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;1: 829-32.
5. Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedule mammography rescreening in the National Breast and Cervical Cancer Early Detection Program. Cancer Epidemiol Biomarkers Prev 2004; 13:620-30.
6. Bulliard JL, De Landtsheer JP, Levi F. Reattendance in the Swiss mammography screening pilot programme. J Med Screen 2004;11: 59-64.
7. Drossaert CH, Boer H, Seydel ER. Monitoring women's experiences during three rounds of breast cancer screening: results from a longitudinal study. J Med Screen 2002;9:168-75.
8. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 1998;75:694-8.
9. Hofvind SS, Wang H, Thoresen S. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result. Cancer Causes Control 2003;14:391-8.
10. Wadden N, Doyle GP. Breast cancer screening in Canada: a review. Can Assoc Radiol J 2005;56:271-5.
11. Johnson MM, Hislop TG, Kan L, Coldman AJ, Lai A. Compliance with the screening mammography program of British Columbia: will she return? Cancer J Public Health 1996;87:176-80.
12. Partin MR, Slater JS. Promoting repeat mammography use: insights from a systematic needs assessment. Health Educ Behav 2003;30: 97-112.
13. Cockburn J, Schofield P, White V, Hill D, Russell I. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia. J Epidemiol Community Health 1997;51:62-6.
14. Achat H, Close G, Taylor R. Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med 2005;41:312-20.
15. Halabi S, Skinner CS, Samsa GP, Strigo TS, Crawford YS, Rimer BK. Factors associated with repeat mammography screening. J Fam Pract 2000;49:1104-12.
16. Hitchcock JL, Steckevicz MJ, Thompson WD. Screening mammography: factors associated with adherence to recommended age/ frequency guidelines. Womens Health 1995;1:221-35.
17. Rakowski W, Meissner H, Vernon SW, Breen N, Rimer B, Clark MA. Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS 2003). Cancer Epidemiol Biomarkers Prev 2006;15: 2093-101.
18. Aiken LS, West SG, Woodward CK, Reno RR. Health beliefs and compliance with mammography-screening recommendations in asymptomatic women. Health Psychol 1994;13:122-9.
19. Mayne L, Earp J. Initial and repeat mammography screening: different behaviors/different predictors. J Rural Health 2003;19:63-71.
20. Pakenham KI, Pruss M, Clutton S. The utility of socio-demographics, knowledge and health belief model variables in predicting reattendance for mammography screening: a brief report. Psychol Health 2000;15:585-91.
21. Baines CJ, To T, Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer 1990;65:1663-9.
22. Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 1994;16:79-86.
23. Orton M, Fitzpatrick R, Fuller A, Mant D, Mlynek C, Thorogood M. Factors affecting women's response to an invitation to attend for a second breast cancer screening examination. Br J Gen Pract 1991; 41:320-2.
24. Chiarelli AM, Halapy E, Nadalin V, Shumak R, O'Malley F, Mai V. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000. Eur J Cancer Prev 2006;15:34-42.
25. Libstug AR, Moravan V, Aitken SE. Results from the Ontario breast screening program, 1990-1995. J Med Screen 1998;5:73-80.
26. Holowaty EJ, Marrett LD, Fehringer G. Methods. In: Cancer incidence in Ontario: trends and regional variations in the 1980s. Toronto, Ontario: Publications Ontario; 1995. p. 6.
27. Marrett LD, Swift M, Reynolds DL, Clarke EA. Geographic distribution of cancer in Ontario, volume 1: atlas of cancer mortality, 1976-1985. Toronto, Ontario: Ontario Cancer Treatment and Research Foundation; 1995.
28. Jaro MA. Probabilistic linkage of large public health data files. Stat Med 1995;14:491-8.
29. SAS Institute, Inc. Statistical Analysis Software. 9.1.2 ed. Cary (NC): SAS Institute; 2004.
30. Diggle PJ, Heagerty P, Liang K, Zeger SL. Analysis of longitudinal data. Oxford (United Kingdom): Oxford University Press; 2002.
31. Breslow NE, Clayton DG. Approximate inference in generalized linear mixed models. J Am Stat Assoc 1993;88:9-25.
32. R Development Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2009.
33. Edwards SA, Chiarelli AM, Stewart L, Majpruz V, Ritvo P, Mai V. Predisposing factors associated with compliance to biennial breast screening among centers with and without nurses. Cancer Epidemiol Biomarkers Prev 2009;18:739-47.
34. Scaf-Klomp W, van Sonderen FL, Stewart R, van Dijck JA, van den Heuvel WJ. Compliance after 17 years of breast cancer screening. J Med Screen 1995;2:195-9.
35. Chiarelli AM, Moravan V, Halapy E, Majpruz V, Mai V, Tatla RK. False-positive result and reattendance in the Ontario Breast Screening Program. J Med Screen 2003;10:129-33.
36. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-10.
37. Yang Q, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD. Family history score as a predictor of breast cancer mortality: prospective data from the Cancer Prevention Study II, United States, 1982-1991. Am J Epidemiol 1998;147:652-9.
38. Degnan D, Harris R, Ranney J, Quade D, Earp JA, Gonzalez J. Measuring the use of mammography: two methods compared. Am J Public Health 1992;82:1386-8.
39. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993;85:566-70.
40. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990;131:815-25.
41. Theis B, Boyd N, Lockwood G, Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 1994;3:321-7.